See clearly.
Treat optimally.

How can we help you?

Contact information

* This field is mandatory

Country

First name*

First name (phonetic)

Last name*

Last name (phonetic)

Salutation

Academic title

Email address*

Business phone

Company*

Job title

Industry

Function

Specialty

Department

State or Province

City

Address

Zip or Postal Code

By specifying your reason for contact we will be able to provide you with a better service.

Follow up information

Preferred method of contact

Best time to call

Estimated time of purchase

Comments

What is cross border data transfer?

I agree on cross-border transfer of personal information.

CEE specific legal checkbox

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behavior.

Final CEE consent

50%

who undergo an amputation die within 5 years²

This year
600,000
people

will be diagnosed with new venous ulcers¹

22%

of US adults suffer from chronic venous insufficiency⁵

Venous disease is the
#1 cause

of lower extremity ulcers worldwide¹

¼ of a billion

people worldwide suffer from PAD³

Every
30

seconds a diabetic patient somewhere in the world has a limb amputated⁴

Arterial

Visualize the best path forward with IVUS eyes

Philips IVUS provides the visualization to gain deeper insights into the lesion and choose the best procedural path forward.
IVUS may help to determine:

Lumen

Eccentric fibrotic plaque with deep calcium module

Accoustic shadowing

Additional education resources

AV access

IVUS changed 76% of AV access graft treatment plans⁷

N= 100 patients P = .16

Median time to first AV graft reintervention or discontinuation

In a prospective randomized single-center pilot study, the investigators suggest that using IVUS with DSA during endovascular interventions of failing hemodialysis access grafts holds potential to extend the time to the first reintervention.

Additional education resources

Venous

IVUS changed 57% of venous treatment plans⁸

Distribution of treatment plan changes in 57 of 100 patients

Changed plan from no treatment to stent placement

Changed number of stents planned

Changed plan from no treatment to other intervention

Changed plan from treatment to no treatment

Additional education resources

Products

Peripheral IVUS catheters

Philips Image Guided Therapy (IGT) Devices provides a full line of IVUS catheters to help guide your treatment approach for peripheral applications.

Visions PV .014 RX

Visions PV .018

Visions PV .035

IVUS compatible systems

Core Mobile

Core

Core M2

IntraSight

Take the step with PVD and Me

Learn more about the most common PVD conditions which vary in progression, symptoms, diagnostics and treatment. Find out when to call a doctor and how patients are living with PVD today.

* Co-registration tools available within IntraSight 7 configuration via SyncVision

1. Eberhardt RT, 2014, Pappas PJ 2005, Bongiovanni CM, 2006 and THE SAGE GROUP.

2. Davies MG, Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4): 10–14.

3. Fowkes FG, et al., Lancet. 2013 Oct 19;382(9901):1329-40.

4. Teraa M., et al. J Am Heart Assoc. 2016 Feb 23;5(2). pii: e002938; 5. J Vasc Surg 1996;23:172-181.

5. J Vasc Surg 1996;23:172-181.

6. Kashyap VS. Pavkov ML, Bishop PD, et al. Angiography underestimates peripheral atherosclerosis: lumenography revisited. J Endovasc Ther. 2008;15(1): 117-125.

7. Ross, J. et al. Role of intravascular ultrasound imaging during endovascular interventions of failing hemodialysis access grafts, J Vasc Surg 2017;65(5): 1383-1389.

8. Gagne PG, Tahara RW, Fastabend CP,et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg:Venous and Lym Dis 2017;5:678-87.

See clearly. Treat optimally.

Contact information

50%

This year 600,000 people

22%

Venous disease is the #1 cause

¼ of a billion

Every 30

Arterial

Visualize the best path forward with IVUS eyes

AV access

N= 100 patients P = .16

Median time to first AV graft reintervention or discontinuation

Venous

Distribution of treatment plan changes in 57 of 100 patients

Changed plan from no treatment to stent placement

Changed number of stents planned

Changed plan from no treatment to other intervention

Changed plan from treatment to no treatment

Products

Peripheral IVUS catheters

IVUS compatible systems

Take the step with PVD and Me

See clearly.
Treat optimally.

This year
600,000
people

Venous disease is the
#1 cause

Every
30